Is EUDA or BDSX more profitable?

EUDA Health has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. EUDA Health's return on equity of 0.00% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Biodesix -33.26% -2,101.40% -35.65%

Does the media favor EUDA or BDSX?

In the previous week, EUDA Health and EUDA Health both had 1 articles in the media. Biodesix's average media sentiment score of 1.10 beat EUDA Health's score of 0.97 indicating that Biodesix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Biodesix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is EUDA or XGN more profitable?

EUDA Health has a net margin of 0.00% compared to Exagen's net margin of -29.49%. EUDA Health's return on equity of 0.00% beat Exagen's return on equity. Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Exagen -29.49% -94.37% -28.96%

Do analysts recommend BNR or EUDA?

EUDA Health has a consensus target price of $55.00, suggesting a potential upside of 251.42%. Given EUDA Health's stronger consensus rating and higher possible upside, analysts clearly believe EUDA Health is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor BNR or EUDA?

In the previous week, Burning Rock Biotech had 1 more articles in the media than EUDA Health. MarketBeat recorded 2 mentions for Burning Rock Biotech and 1 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.97 beat Burning Rock Biotech's score of 0.00 indicating that EUDA Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, EUDA or PARK?

Park Dental Partners has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M 6.87 -$2.77M -$2.40 N/A Park Dental Partners $244.49M 0.34 N/A N/A N/A

Is EUDA or PARK more profitable?

Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Park Dental Partners N/A N/A N/A

Does the media favor EUDA or PARK?

In the previous week, Park Dental Partners had 4 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Park Dental Partners and 1 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.97 beat Park Dental Partners' score of 0.00 indicating that EUDA Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Park Dental Partners 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

EUDA Health (EUDA) Competitors

$15.65 -0.41 (-2.55%)

As of 12:16 PM Eastern

Compare

EUDA vs. BDSX, XGN, BNR, PIII, and PARK

Should you buy EUDA Health stock or one of its competitors? MarketBeat compares EUDA Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with EUDA Health include Biodesix (BDSX), Exagen (XGN), Burning Rock Biotech (BNR), P3 Health Partners (PIII), and Park Dental Partners (PARK). These companies are all part of the "healthcare" industry.

How does EUDA Health compare to Biodesix?

EUDA Health (NASDAQ:EUDA) and Biodesix (NASDAQ:BDSX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

EUDA Health has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Biodesix has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. EUDA Health's return on equity of 0.00% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Biodesix	-33.26%	-2,101.40%	-35.65%

EUDA Health presently has a consensus target price of $55.00, suggesting a potential upside of 251.42%. Biodesix has a consensus target price of $22.00, suggesting a potential upside of 49.81%. Given EUDA Health's higher possible upside, research analysts plainly believe EUDA Health is more favorable than Biodesix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biodesix	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

EUDA Health has higher earnings, but lower revenue than Biodesix. EUDA Health is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.87	-$2.77M	-$2.40	N/A
Biodesix	$88.50M	1.72	-$35.26M	-$4.06	N/A

4.3% of EUDA Health shares are held by institutional investors. Comparatively, 21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, EUDA Health and EUDA Health both had 1 articles in the media. Biodesix's average media sentiment score of 1.10 beat EUDA Health's score of 0.97 indicating that Biodesix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Biodesix	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

EUDA Health beats Biodesix on 8 of the 15 factors compared between the two stocks.

How does EUDA Health compare to Exagen?

EUDA Health (NASDAQ:EUDA) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

4.3% of EUDA Health shares are held by institutional investors. Comparatively, 75.3% of Exagen shares are held by institutional investors. 10.4% of Exagen shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, EUDA Health had 1 more articles in the media than Exagen. MarketBeat recorded 1 mentions for EUDA Health and 0 mentions for Exagen. EUDA Health's average media sentiment score of 0.97 beat Exagen's score of 0.00 indicating that EUDA Health is being referred to more favorably in the media.

Company	Overall Sentiment
EUDA Health	Positive
Exagen	Neutral

EUDA Health has a net margin of 0.00% compared to Exagen's net margin of -29.49%. EUDA Health's return on equity of 0.00% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Exagen	-29.49%	-94.37%	-28.96%

EUDA Health has higher earnings, but lower revenue than Exagen. EUDA Health is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.87	-$2.77M	-$2.40	N/A
Exagen	$66.57M	1.54	-$19.95M	-$0.89	N/A

EUDA Health has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Exagen has a beta of 2.01, suggesting that its share price is 101% more volatile than the broader market.

EUDA Health currently has a consensus price target of $55.00, suggesting a potential upside of 251.42%. Exagen has a consensus price target of $9.25, suggesting a potential upside of 118.26%. Given EUDA Health's higher possible upside, equities research analysts plainly believe EUDA Health is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

EUDA Health and Exagen tied by winning 8 of the 16 factors compared between the two stocks.

How does EUDA Health compare to Burning Rock Biotech?

Burning Rock Biotech (NASDAQ:BNR) and EUDA Health (NASDAQ:EUDA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

In the previous week, Burning Rock Biotech had 1 more articles in the media than EUDA Health. MarketBeat recorded 2 mentions for Burning Rock Biotech and 1 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.97 beat Burning Rock Biotech's score of 0.00 indicating that EUDA Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Burning Rock Biotech has a beta of 1.33, suggesting that its stock price is 33% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

EUDA Health has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than EUDA Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.15	-$7.92M	-$0.79	N/A
EUDA Health	$6.82M	6.87	-$2.77M	-$2.40	N/A

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 4.3% of EUDA Health shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

EUDA Health has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -10.27%. EUDA Health's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-10.27%	-9.98%	-6.69%
EUDA Health	N/A	N/A	N/A

EUDA Health has a consensus target price of $55.00, suggesting a potential upside of 251.42%. Given EUDA Health's stronger consensus rating and higher possible upside, analysts clearly believe EUDA Health is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

EUDA Health beats Burning Rock Biotech on 10 of the 16 factors compared between the two stocks.

How does EUDA Health compare to P3 Health Partners?

EUDA Health (NASDAQ:EUDA) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.

EUDA Health has higher earnings, but lower revenue than P3 Health Partners. EUDA Health is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.87	-$2.77M	-$2.40	N/A
P3 Health Partners	$1.47B	0.06	-$147.95M	-$38.60	N/A

In the previous week, EUDA Health had 1 more articles in the media than P3 Health Partners. MarketBeat recorded 1 mentions for EUDA Health and 0 mentions for P3 Health Partners. EUDA Health's average media sentiment score of 0.97 beat P3 Health Partners' score of 0.00 indicating that EUDA Health is being referred to more favorably in the media.

Company	Overall Sentiment
EUDA Health	Positive
P3 Health Partners	Neutral

EUDA Health has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

EUDA Health currently has a consensus price target of $55.00, indicating a potential upside of 251.42%. P3 Health Partners has a consensus price target of $14.00, indicating a potential upside of 24.89%. Given EUDA Health's higher probable upside, equities research analysts clearly believe EUDA Health is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

EUDA Health has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%. EUDA Health's return on equity of 0.00% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
P3 Health Partners	-8.57%	-302.33%	-19.99%

4.3% of EUDA Health shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 17.8% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

EUDA Health beats P3 Health Partners on 9 of the 14 factors compared between the two stocks.

How does EUDA Health compare to Park Dental Partners?

EUDA Health (NASDAQ:EUDA) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

Park Dental Partners has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.87	-$2.77M	-$2.40	N/A
Park Dental Partners	$244.49M	0.34	N/A	N/A	N/A

In the previous week, Park Dental Partners had 4 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Park Dental Partners and 1 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.97 beat Park Dental Partners' score of 0.00 indicating that EUDA Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Park Dental Partners	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

EUDA Health presently has a consensus target price of $55.00, suggesting a potential upside of 251.42%. Park Dental Partners has a consensus target price of $21.75, suggesting a potential upside of 17.76%. Given EUDA Health's higher probable upside, research analysts clearly believe EUDA Health is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	2.75

4.3% of EUDA Health shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Park Dental Partners	N/A	N/A	N/A

Summary

EUDA Health and Park Dental Partners tied by winning 5 of the 10 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EUDA vs. The Competition

Export

Metric	EUDA Health	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$46.86M	$1.51B	$6.45B	$11.84B
Dividend Yield	N/A	N/A	2.67%	5.58%
P/E Ratio	-6.52	77.57	23.86	23.56
Price / Sales	6.87	22.14	530.02	114.80
Price / Cash	N/A	22.89	26.99	37.25
Price / Book	-6.93	4.74	10.56	6.66
Net Income	-$2.77M	-$54.76M	$3.56B	$337.25M
7 Day Performance	-7.50%	-6.08%	-1.58%	-2.53%
1 Month Performance	13.74%	-0.61%	0.85%	1.33%
1 Year Performance	-76.71%	-12.02%	20.08%	23.50%

EUDA Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EUDA EUDA Health	2.6058 of 5 stars	$15.65 -2.5%	$55.00 +251.4%	-77.5%	$46.86M	$6.82M	N/A	2	News Coverage
BDSX Biodesix	3.7324 of 5 stars	$16.10 +4.3%	$22.00 +36.6%	+146.8%	$159.89M	$88.50M	N/A	220	News Coverage Positive News
XGN Exagen	3.4958 of 5 stars	$4.54 -5.8%	$9.25 +103.7%	-42.1%	$116.45M	$66.57M	N/A	220
BNR Burning Rock Biotech	0.8951 of 5 stars	$8.81 -8.6%	N/A	+212.8%	$101.40M	$77.16M	N/A	1,390	News Coverage Earnings Report
PIII P3 Health Partners	1.3699 of 5 stars	$10.05 -21.4%	$14.00 +39.3%	+85.0%	$92.66M	$1.46B	N/A	500	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EUDA) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EUDA Health (EUDA) Competitors

EUDA vs. BDSX, XGN, BNR, PIII, and PARK

How does EUDA Health compare to Biodesix?

Summary

How does EUDA Health compare to Exagen?

Summary

How does EUDA Health compare to Burning Rock Biotech?

Summary

How does EUDA Health compare to P3 Health Partners?

Summary

How does EUDA Health compare to Park Dental Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EUDA Health (EUDA) Competitors

EUDA vs. BDSX, XGN, BNR, PIII, and PARK

How does EUDA Health compare to Biodesix?

Which has more volatility and risk, EUDA or BDSX?

Is EUDA or BDSX more profitable?

Do analysts prefer EUDA or BDSX?

Which has better valuation and earnings, EUDA or BDSX?

Do insiders and institutionals hold more shares of EUDA or BDSX?

Does the media favor EUDA or BDSX?

Summary

How does EUDA Health compare to Exagen?

Do insiders and institutionals believe in EUDA or XGN?

Does the media refer more to EUDA or XGN?

Is EUDA or XGN more profitable?

Which has preferable valuation & earnings, EUDA or XGN?

Which has more volatility & risk, EUDA or XGN?

Do analysts rate EUDA or XGN?

Summary

How does EUDA Health compare to Burning Rock Biotech?

Does the media favor BNR or EUDA?

Which has more volatility and risk, BNR or EUDA?

Which has higher earnings & valuation, BNR or EUDA?

Do institutionals and insiders hold more shares of BNR or EUDA?

Is BNR or EUDA more profitable?

Do analysts recommend BNR or EUDA?

Summary

How does EUDA Health compare to P3 Health Partners?

Which has better valuation and earnings, EUDA or PIII?

Does the media favor EUDA or PIII?

Which has more risk and volatility, EUDA or PIII?

Do analysts recommend EUDA or PIII?

Is EUDA or PIII more profitable?

Do insiders & institutionals believe in EUDA or PIII?

Summary

How does EUDA Health compare to Park Dental Partners?

Which has higher valuation and earnings, EUDA or PARK?

Does the media favor EUDA or PARK?

Do analysts recommend EUDA or PARK?

Do insiders and institutionals hold more shares of EUDA or PARK?

Is EUDA or PARK more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools